These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Some structural antigens of herpes simplex virus type 1. Powell KL, Watson DH. J Gen Virol; 1975 Nov; 29(2):167-78. PubMed ID: 213527 [Abstract] [Full Text] [Related]
8. Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope. Bolognesi DP, Bauer H, Gelderblom H, Hüper G. Virology; 1972 Mar; 47(3):551-66. PubMed ID: 4111052 [No Abstract] [Full Text] [Related]
9. Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens. Kutinová L, Slichtová V, Vonka V. Arch Virol; 1979 Mar; 61(1-2):141-7. PubMed ID: 229789 [Abstract] [Full Text] [Related]
10. Comparative complement fixation and serum neutralization antibody titers to herpes simplex virus type 1 and Herpesvirus simiae in Macaca mulatta and humans. Gary GW, Palmer EL. J Clin Microbiol; 1977 Apr; 5(4):465-70. PubMed ID: 192762 [Abstract] [Full Text] [Related]
11. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. Cohen GH, Ponce de Leon M, Nichols C. J Virol; 1972 Nov; 10(5):1021-30. PubMed ID: 4344251 [Abstract] [Full Text] [Related]
12. Immunological specificity of the glycoproteins of herpes simplex virus subtypes 1 and 2. Savage T, Roizman B, Heine JW. J Gen Virol; 1972 Oct; 17(1):31-48. PubMed ID: 4343529 [No Abstract] [Full Text] [Related]
13. Effect of antigenic stimulation on the specificity of antibody produced by rabbits immunized with bacteriophage MS-2. Krueger RG. J Immunol; 1970 May; 104(5):1117-23. PubMed ID: 4192153 [No Abstract] [Full Text] [Related]
14. Autogenous immunity to endogenous RNA tumor virus: differential reactivities of immunoglobulins M and G to virus envelope antigens. Lee JC, Hanna MG, Ihle JN, Aaronson SA. J Virol; 1974 Oct; 14(4):773-81. PubMed ID: 4138466 [Abstract] [Full Text] [Related]
15. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection. Sherlock CH, Ashley RL, Shurtleff ML, Mack KD, Corey L. J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439 [Abstract] [Full Text] [Related]
16. Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis. Vestergaard BF. Rev Infect Dis; 1980 Dec; 2(6):899-913. PubMed ID: 6164087 [Abstract] [Full Text] [Related]
17. Detection of antibodies specific for herpes simplex virus in human sera by the enzyme-linked immunosorbent assay. Gilman SC, Docherty JJ. J Infect Dis; 1977 Oct; 136 Suppl():S286-93. PubMed ID: 198491 [Abstract] [Full Text] [Related]
18. [Immunologic analysis of the two Herpes simplex type viruses]. Schneweis KE. Zentralbl Bakteriol Orig A; 1972 May; 220(1):95-7. PubMed ID: 4145642 [No Abstract] [Full Text] [Related]
19. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody. Glorioso JC, Wilson LA, Fenger TW, Smith JW. J Gen Virol; 1978 Aug; 40(2):443-54. PubMed ID: 211189 [Abstract] [Full Text] [Related]
20. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins. Eing BR, Kühn JE, Braun RW. J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]